TNF and infection: A meta-analysis that compared the safety of biological drugs (mostly anti-TNF drugs) across age groups for immune-mediated diseases showed that infections were more prevalent in elderly patients treated with biologics than in younger patients treated with the same therapies (OR 2.28) and in elderly patients not treated with biologics (OR 3.60).